<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:com="http://www.sec.gov/edgar/common">
    <schemaVersion>X0202</schemaVersion>
<headerData>
        <submissionType>SCHEDULE 13G</submissionType>
        <filerInfo>
            <filer>
                <filerCredentials>
                    <cik>0001985486</cik>
                    <ccc>XXXXXXXX</ccc>
                </filerCredentials>
            </filer>
            <liveTestFlag>LIVE</liveTestFlag>


        </filerInfo>
    </headerData>
    <formData>
        <coverPageHeader>
            <securitiesClassTitle>SHS SUB VTG</securitiesClassTitle>
            <eventDateRequiresFilingThisStatement>03/31/2026</eventDateRequiresFilingThisStatement>
            <issuerInfo>
                <issuerCik>0001690511</issuerCik>
                <issuerName>Canada Goose Holdings Inc</issuerName>
                <issuerCusips>
                    <issuerCusipNumber>135086106</issuerCusipNumber>
                </issuerCusips>
                <issuerPrincipalExecutiveOfficeAddress>
                    <com:street1>250 Bowie Avenue</com:street1>
                    <com:city>Toronto</com:city>
                    <com:stateOrCountry>A6</com:stateOrCountry>
                    <com:zipCode>M6E 4Y2</com:zipCode>
                </issuerPrincipalExecutiveOfficeAddress>
            </issuerInfo>
            <designateRulesPursuantThisScheduleFiled>
                <designateRulePursuantThisScheduleFiled>Rule 13d-1(b)</designateRulePursuantThisScheduleFiled>
            </designateRulesPursuantThisScheduleFiled>
        </coverPageHeader>
        <coverPageHeaderReportingPersonDetails>

            <reportingPersonName>Ilex Capital Partners (UK) LLP</reportingPersonName>
            <citizenshipOrOrganization>X0</citizenshipOrOrganization>
            <reportingPersonBeneficiallyOwnedNumberOfShares>
                <soleVotingPower>1873174.00</soleVotingPower>
                <sharedVotingPower>0</sharedVotingPower>
                <soleDispositivePower>1873174.00</soleDispositivePower>
                <sharedDispositivePower>0</sharedDispositivePower>
            </reportingPersonBeneficiallyOwnedNumberOfShares>
            <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>1873174.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
            <classPercent>4.1</classPercent>
            <typeOfReportingPerson>FI</typeOfReportingPerson>
        </coverPageHeaderReportingPersonDetails>
        <items>
            <item1>
                <issuerName>Canada Goose Holdings Inc</issuerName>
                <issuerPrincipalExecutiveOfficeAddress>250 Bowie Avenue, Toronto, CA-ON, M6E 4Y2, CA</issuerPrincipalExecutiveOfficeAddress>
            </item1>
            <item2>
                <filingPersonName>Ilex Capital Partners (UK) LLP, Ilex Master Fund LP</filingPersonName>
                <principalBusinessOfficeOrResidenceAddress>Ilex Capital Partners (UK) LLP - The Kensington Building, 1 Wrights Lane, London, W8 5RY, Kensington And Chelsea, United Kingdom / Ilex Master Fund LP - Please enter the full address of the portfolio</principalBusinessOfficeOrResidenceAddress>
                <citizenship>Ilex Capital Partners (UK) LLP - United Kingdom, Ilex Master Fund LP - Please fill in the Country</citizenship>
            </item2>
            <item3>
                <notApplicableFlag>N</notApplicableFlag>
                <typeOfPersonFiling>FI</typeOfPersonFiling>
                <otherTypeOfPersonFiling>Ilex Capital Partners (UK) LLP is authorised and regulated as Alternative Investment Fund Manager by the Financial Conduct Authority.</otherTypeOfPersonFiling>
            </item3>
            <item4>
                <amountBeneficiallyOwned>1,873,174</amountBeneficiallyOwned>
                <classPercent>4.1</classPercent>
                <numberOfSharesPersonHas>
                    <solePowerOrDirectToVote>1,873,174</solePowerOrDirectToVote>
                    <sharedPowerOrDirectToVote>0</sharedPowerOrDirectToVote>
                    <solePowerOrDirectToDispose>1,873,174</solePowerOrDirectToDispose>
                    <sharedPowerOrDirectToDispose>0</sharedPowerOrDirectToDispose>
                </numberOfSharesPersonHas>
            </item4>
            <item5>
                <notApplicableFlag>N</notApplicableFlag>
                <classOwnership5PercentOrLess>Y</classOwnership5PercentOrLess>
            </item5>
            <item6>
                <notApplicableFlag>Y</notApplicableFlag>
            </item6>
            <item7>
                <notApplicableFlag>Y</notApplicableFlag>
            </item7>
            <item8>
                <notApplicableFlag>Y</notApplicableFlag>
            </item8>
            <item9>
                <notApplicableFlag>Y</notApplicableFlag>
            </item9>
            <item10>
                <notApplicableFlag>N</notApplicableFlag>
                <certifications>By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. </certifications>
            </item10>
        </items>
        <signatureInformation>
            <reportingPersonName>Ilex Capital Partners (UK) LLP</reportingPersonName>
            <signatureDetails>
                <signature>Driton Bilali</signature>
                <title>Chief Compliance Officer</title>
                <date>05/14/2026</date>
            </signatureDetails>
        </signatureInformation>
    </formData>
</edgarSubmission>
